Amicogen
At a glance
Amicogen filed 73 disclosures in the last 12 months, including 6 insider, 2 issuance and 1 5% holder. The most recent key filing was on Sep 3.
Revenue for 2025 was ₩42B, down 75.8% on 2024. It made an operating loss of ₩17.1B. Debt was 142% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩25.7B and operating loss of ₩4.5B.
The 2025 annual report lists 228 employees with an average tenure of 6.3 years and average pay of ₩49.7M, #1461 of 1,829 listed companies by average pay. Its 7 directors and auditors were paid ₩94M each on average. It paid no cash dividend for 2025. 마가파트너스투자조합 and related parties held 4.59% at year end.
From the 2025 annual report
Staff: 228 (163 men, 65 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩11.4B. Directors and auditors: 7, paid ₩661M in total.
No cash dividend was paid for 2025.
Largest shareholder
마가파트너스투자조합 holds 3.90%; with 4 related parties the group holds 4.59% of common shares at year end (from 0.45% at the start of the year).
Auditor: 삼덕회계법인 · opinion: Unqualified.
Source: 2025 annual business report (DART). How figures are combined
Financial summary
Key filings
Other filings
Links open the original filing on DART, in Korean.